Event JSON
{
"id": "433cddb31767f8135832f91e15af111a0ae44b4987100fdf7203dab17f1d9190",
"pubkey": "af947eb1ac2a94a86b48cbbda851396b8bcaa9aa59c9322e7c3da8264e0e9878",
"created_at": 1734536196,
"kind": 1,
"tags": [
[
"r",
"https://en.globes.co.il/en/article-1001497164#utm_source=RSS"
],
[
"subject",
"Teva share price at 6-year high after trial results"
],
[
"published_at",
"1734542694"
],
[
"image",
"https://res.cloudinary.com/globes/image/upload/t_800X392/v1708440634/direct/%D7%A8%D7%99%D7%A6%D7%A8%D7%93_%D7%A4%D7%A8%D7%A0%D7%A1%D7%99%D7%A1_%D7%A0%D7%A9%D7%99%D7%90_%D7%95%D7%9E%D7%A0%D7%9B%D7%9C_%D7%98%D7%91%D7%A2_%D7%9E%D7%9E%D7%A4%D7%92%D7%A9_%D7%94%D7%A2%D7%99%D7%AA%D7%95%D7%A0%D7%90%D7%99%D7%9D_%D7%A6%D7%99%D7%9C%D7%95%D7%9D_%D7%93%D7%95%D7%91%D7%A8%D7%95%D7%AA_%D7%98%D7%91%D7%A2_5_jiva6a.jpg"
],
[
"p",
"af947eb1ac2a94a86b48cbbda851396b8bcaa9aa59c9322e7c3da8264e0e9878",
"wss://relay-testnet.k8s.layer3.news"
],
[
"imeta",
"url https://res.cloudinary.com/globes/image/upload/t_800X392/v1708440634/direct/%D7%A8%D7%99%D7%A6%D7%A8%D7%93_%D7%A4%D7%A8%D7%A0%D7%A1%D7%99%D7%A1_%D7%A0%D7%A9%D7%99%D7%90_%D7%95%D7%9E%D7%A0%D7%9B%D7%9C_%D7%98%D7%91%D7%A2_%D7%9E%D7%9E%D7%A4%D7%92%D7%A9_%D7%94%D7%A2%D7%99%D7%AA%D7%95%D7%A0%D7%90%D7%99%D7%9D_%D7%A6%D7%99%D7%9C%D7%95%D7%9D_%D7%93%D7%95%D7%91%D7%A8%D7%95%D7%AA_%D7%98%D7%91%D7%A2_5_jiva6a.jpg"
],
[
"t",
"unkown:perspective"
],
[
"summary",
"Teva's market cap rose to a six-year high of $23.7 billion, making it the most valuable Israeli company on Wall Street. The company's recovery over the past year has been remarkable, with its market value doubling and now trading at a value three times higher than its low in 2020. The latest increase is attributed to the publication of successful Phase 2b trial results for Dukavitug, a treatment for ulcerative colitis and Crohn's disease."
]
],
"content": "nostr:nprofile1qy3hwumn8ghj7un9d3shjtt5v4ehgmn9wshxkwrn9ekxz7t9wgejumn9waesqg90j3ltrtp2jj5xkjxthk59zwtt3092n2jeeyezulpa4qnyur5c0qh5y6qj\nhttps://res.cloudinary.com/globes/image/upload/t_800X392/v1708440634/direct/%D7%A8%D7%99%D7%A6%D7%A8%D7%93_%D7%A4%D7%A8%D7%A0%D7%A1%D7%99%D7%A1_%D7%A0%D7%A9%D7%99%D7%90_%D7%95%D7%9E%D7%A0%D7%9B%D7%9C_%D7%98%D7%91%D7%A2_%D7%9E%D7%9E%D7%A4%D7%92%D7%A9_%D7%94%D7%A2%D7%99%D7%AA%D7%95%D7%A0%D7%90%D7%99%D7%9D_%D7%A6%D7%99%D7%9C%D7%95%D7%9D_%D7%93%D7%95%D7%91%D7%A8%D7%95%D7%AA_%D7%98%D7%91%D7%A2_5_jiva6a.jpg\nThe Israeli pharmaceutical company's market cap gained $5 billion in one Wall Street session boosting Israeli pension funds by hundreds of millions of dollars.\nhttps://en.globes.co.il/en/article-1001497164#utm_source=RSS",
"sig": "d24338fd8a28b07129f56689e854c66dbb65b1fe83ba111e7e92fd571e3c06790cc418ceb21e468facd9f23e74bbc5b46694913de83a3b9f0493b5f98bed9a52"
}
